M C Nash1, A M Wade. Show Affiliations » 1. Medical Unit, Institute of Child Health, London, UK.
Abstract
Entities: Chemical Disease
Mesh： See more » Administration, OralChildCombined Modality TherapyDose-Response Relationship, DrugHumansMucocutaneous Lymph Node Syndrome/drug therapyPentoxifylline/therapeutic useTreatment OutcomeTumor Necrosis Factor-alpha/antagonists & inhibitorsVasodilator Agents/therapeutic use
Substances： See more » Tumor Necrosis Factor-alphaVasodilator AgentsPentoxifylline
Year: 1996 PMID： 8929744 DOI： 10.1007/bf01953955
Source DB: PubMed Journal: Eur J Pediatr ISSN： 0340-6199 Impact factor: 3.183